Gene: LDLRAP1
Official Full Name: low density lipoprotein receptor adaptor protein 1provided by HGNC
Gene Summary: The protein encoded by this gene is a cytosolic protein which contains a phosphotyrosine binding (PTD) domain. The PTD domain has been found to interact with the cytoplasmic tail of the LDL receptor. Mutations in this gene lead to LDL receptor malfunction and cause the disorder autosomal recessive hypercholesterolaemia. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28314 | LDLRAP1 Knockout cell line (HeLa) | Human | LDLRAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO28315 | LDLRAP1 Knockout cell line (HCT 116) | Human | LDLRAP1 | 1:2~1:4 | Negative | Online Inquiry |
KO28316 | LDLRAP1 Knockout cell line (HEK293) | Human | LDLRAP1 | 1:3~1:6 | Negative | Online Inquiry |
KO28317 | LDLRAP1 Knockout cell line (A549) | Human | LDLRAP1 | 1:3~1:4 | Negative | Online Inquiry |
LDLRAP1 Gene Knockout Cell Lines are specialized cellular models engineered for comprehensive study of the low-density lipoprotein receptor adaptor protein 1 (LDLRAP1) gene. This genetic alteration facilitates the investigation of LDLRAP1’s role in cellular processes, particularly in lipid metabolism and cholesterol homeostasis. By disrupting the LDLRAP1 gene, researchers can simulate conditions akin to genetic disorders like familial hypercholesterolemia, providing critical insight into the underlying mechanisms of lipid regulation and cardiovascular health.
The primary function of these knockout cell lines is to enable researchers to examine how the absence of LDLRAP1 affects cellular responses to low-density lipoproteins (LDL), significantly influencing pathways related to receptor-mediated endocytosis. The mechanistic understanding gained from these studies is invaluable, as it helps to elucidate the broader implications of LDLRAP1 in disease processes, thus paving the way for innovative therapeutic strategies.
In both research and clinical applications, these cell lines are crucial for drug development, fundamental biology studies, and biomarker discovery in cardiovascular diseases and metabolic disorders. Their ability to provide a controlled environment for experimentation sets them apart from traditional models. Unlike standard cell lines that may exhibit variability in receptor expression, LDLRAP1 Gene Knockout Cell Lines ensure specific and consistent outcomes, fostering reproducibility and reliability in data.
For researchers and clinicians focused on cardiovascular health, these cell lines offer a promising tool to advance understanding and improve interventions across lipid disorders. They are backed by our company's decade-long expertise in delivering high-quality biological products, ensuring rigorous validation and user support for successful experimental outcomes. Embrace the potential of LDLRAP1 Gene Knockout Cell Lines to redefine your research in lipid metabolism and enhance the fight against cardiovascular diseases.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.